Tolerogenic Vaccine for Multiple Sclerosis
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
TregTherapeutics Inc
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Ray Holloway
Fiscal Year
2019
Region
Research Triangle
Project Description:
TregTherapeutics was formed in 2017 to advance the development of a novel tolerance-inducing vaccine for Multiple Sclerosis. The tolerogenic vaccine is based upon the research of Professor Mark Mannie at East Carolina University's Brody School of Medicine. TregTherapeutics will use the SRL funds to initiate pre-IND studies.